Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

Clinical trial NCT07537946 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07537946
Sponsor: Tongji Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Metastases

Start date: 2026-05-30
Primary completion: 2031-05-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.